Global Oxygen Concentrators Market 2024-2031

Description

List of Tables

Global Oxygen Concentrators Market Size, Share & Trends Analysis Report by Type (Portable, and Fixed), by Technology (Continuous flow, and Pulse flow) by Application (Chronic Obstructive Pulmonary Disease (COPD), Asthma, Respiratory Distress, and Others)), and by End-User (Hospitals & Clinics, Home Care Settings, and Ambulatory Surgical Centers & Physician Offices)) Forecast Period (2024-2031)

The global oxygen concentrators market is anticipated to grow at a considerable CAGR of 8.5% during the forecast period (2024-2031). The global oxygen concentrator market is expanding owing to factors such as respiratory disorders, aging population, technological advancements, home healthcare, COVID-19, healthcare expenditure, government initiatives, and increased awareness about oxygen therapy. These devices extract oxygen from the air for higher concentrations.

Market Dynamics

Growing prevalence of high disease burden across the globe

Chronic Obstructive Pulmonary Disease (COPD) significantly contributes to the global respiratory disease burden, necessitating effective respiratory therapy solutions such as oxygen therapy, with oxygen concentrators playing a vital role in addressing health issues and mortality rates. According to the Australian Institute of Health and Welfare, in December 2023, individuals diagnosed with COPD experienced higher rates of self-reported health issues, psychological distress, and bodily pain compared to those without the condition. COPD accounted for 3.6% of the overall disease burden and 50.0% of the respiratory disease burden in 2023. Moreover, an estimated $831.6 million was allocated for COPD treatment and management in 2020-21, which constituted 0.6% of total health system expenditure and 18.0% of respiratory condition expenditure. Additionally, COPD was the cause of fatalities in 7,018 individuals in 2021, representing 4.1% of all recorded mortalities.

Increasing demand for technological advancements in oxygen concentrator

The innovations in oxygen concentrator technology, including advanced features such as remote monitoring and smart connectivity, are driving market growth, improving patient comfort and treatment outcomes. According to the United Nations Children's Fund (UNICEF), in August 2021, a total of 62,046 oxygen concentrators were shipped to 104 countries, with a cumulative value of over $46.2 million. Notably, a Chinese trade company received orders for 12,788 oxygen concentrators worth more than $7.8 million.

Market Segmentation

Our in-depth analysis of the global oxygen concentrators market includes the following segments by technology, process, applications, and end-user,

Based on type, the market is sub-segmented into portable, and fixed.
Based on technology, the market is bifurcated into continuous flow and pulse flow.
Based on application, the market is sub-segmented into Chronic Obstructive Pulmonary Disease (COPD), asthma, respiratory distress, and others (sleep apnea, interstitial lung disease, interstitial fibrosis, cystic fibrosis of lungs, postoperative care)
Based on end-users, the market is segmented into hospitals & clinics, home care settings, and ambulatory surgical centers & physician offices.

Portable is Projected to Emerge as the Largest Segment

Based on the type, the global oxygen concentrators market is sub-segmented into portable, and fixed. Among these, the portable sub-segment is expected to hold the largest share of the market. The primary factor supporting the segment's growth includes advanced technologies in oxygen concentrator production, with manufacturers focusing on designing products with improved efficacy and cost-effectiveness to meet increasing demand. For instance, in June 2021, Servotech Power Systems launched medical-grade oxygen concentrators. It planned to introduce 1,00,000 oxygen concentrators in India, with prices starting at $419.81. It collaborated with IISER Bhopal and IIT Jammu, to produce locally and supply hospitals, foundations, and other healthcare facilities with its products.

Home Care Settings Sub-segment to Hold a Considerable Market Share

The trend towards home-based healthcare is increasing owing to rising costs, telemedicine advancements, and patient-centered care, reducing hospital visits and improving patient outcomes. For instance, in April 2023, OxyGo, launched its latest product, the OxyHome 5L Stationary Concentrator. This is designed to provide a continuous oxygen flow of up to 5L per minute for home use. It is a sleek, compact device with a twin blower cooling design, quiet operation, and a 3-year replacement warranty for daily activities.

Regional Outlook

The global oxygen concentrators market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).

Increasing Demand for Healthcare Facilities Drives Market Growth in the Asia-Pacific

India's growing demand for specialized healthcare facilities is boosting the need for advanced medical equipment, including oxygen concentrators, to support respiratory therapy in hospitals, clinics, and home care settings. According to the International Trade Administration (.gov), in January 2024, the Indian healthcare industry experienced significant growth, with its market size expanding from over $370.0 billion in 2022 to a projected $610.0 billion by 2026. This growth is attributed to the increasing demand for specialized and higher-quality healthcare facilities. Furthermore, public spending on healthcare in India is expected to rise from two percent of GDP in 2022 to 2.5% by 2025, with a particular emphasis on providing healthcare services to underprivileged populations. As a result, the medical equipment sector is poised for corresponding growth.

North America Holds Major Market Share

The rise in healthcare expenditure and infrastructure expansion in growing economies has increased the investment in respiratory care equipment such as oxygen concentrators. According to the American Medical Association, in March 2023, health spending in the U.S. reached a total of $4.3 trillion, equivalent to $12,914.0 per capita. This represents a significant decrease in growth compared to the previous year, with a growth rate of only 2.7%. The decline in pandemic-related government expenditures offset the increased utilization of medical goods and services, which rebounded due to delayed care and pent-up demand from 2020.

The major companies serving the global oxygen concentrators market include CAIRE Inc., DeVilbiss Healthcare GmbH, Invacare Corp., Inogen Inc., and Nidek Medical Products Inc., among others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers, and acquisitions to stay competitive in the market. For instance, in August 2023, VGM & Associates partnered with O2 Concepts, a provider of portable oxygen concentrators, to offer continuous flow and high-volume pulse dose oxygen therapy in a 24/7 environment, and their proprietary DNA Technology connectivity solution.

Product Code: OMR2028554

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
1.1. Research Methods and Tools
1.2. Market Breakdown
- 1.2.1. By Segments
- 1.2.2. By Region

2. Market Overview and Insights

2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key Industry Trends
- 2.2.2. Recommendations
- 2.2.3. Conclusion

3. Competitive Landscape

3.1. Key Company Analysis
3.2. Avanos Medical, Inc.
- 1.1.1. Overview
- 1.1.2. Financial Analysis
- 1.1.3. SWOT Analysis
- 1.1.4. Recent Developments
3.3. ESAB Corp.
- 1.1.5. Overview
- 1.1.6. Financial Analysis
- 1.1.7. SWOT Analysis
- 1.1.8. Recent Developments
1.2. Inogen Inc.
- 1.2.1. Overview
- 1.2.2. Financial Analysis
- 1.2.3. SWOT Analysis
- 1.2.4. Recent Developments
1.3. Key Strategy Analysis

2. Market Segmentation

2.1. Global Oxygen Concentrators Market by Type
- 2.1.1. Portable
- 2.1.2. Fixed
2.2. Global Oxygen Concentrators Market by Technology
- 2.2.1. Continuous flow
- 2.2.2. Pulse flow
2.3. Global Oxygen Concentrators Market by Application
- 2.3.1. Chronic Obstructive Pulmonary Disease (COPD)
- 2.3.2. Asthma
- 2.3.3. Respiratory Distress
- 2.3.4. Others (Sleep Apnea, Interstitial Lung Disease, Interstitial Fibrosis, Cystic Fibrosis Of Lungs, Postoperative Care)
2.4. Global Oxygen Concentrators Market by End-User
- 2.4.1. Hospitals & clinics
- 2.4.2. Home care settings
- 2.4.3. Ambulatory surgical centers & physician offices

3. Regional Analysis

3.1. North America
- 3.1.1. United States
- 3.1.2. Canada
3.2. Europe
- 3.2.1. UK
- 3.2.2. Germany
- 3.2.3. Italy
- 3.2.4. Spain
- 3.2.5. France
- 3.2.6. Rest of Europe
3.3. Asia-Pacific
- 3.3.1. China
- 3.3.2. India
- 3.3.3. Japan
- 3.3.4. South Korea
- 3.3.5. Rest of Asia-Pacific
3.4. Rest of the World
- 3.4.1. Latin America
- 3.4.2. The Middle East & Africa

4. Company Profiles

4.1. Beijing North Star Co. Ltd.
4.2. BESCO MEDICAL Ltd.
4.3. BOC Ltd.
4.4. CAIRE Inc.
4.5. DeVilbiss Healthcare GmbH
4.6. ETW International
4.7. Foshan Keyhub Electronic Industries Co., Ltd.
4.8. GVS S.p.A.
4.9. Inova Health System Foundation (Inova)
4.10. Invacare Corp.
4.11. Nidek Medical Products Inc.
4.12. O2 Concepts, LLC
4.13. Oxus America
4.14. Oxygen Plus, Inc.
4.15. OxyGo HQ Florida, LLC.
4.16. Precision Medical, Inc.
4.17. Teijin Ltd.